Virtus ETF Advisers LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$90,504
-19.7%
5,042
-9.1%
0.06%
-17.9%
Q2 2023$112,680
+105.2%
5,548
+84.3%
0.07%
+123.3%
Q1 2023$54,902
-36.3%
3,010
-27.7%
0.03%
-33.3%
Q4 2022$86,153
-35.2%
4,166
-17.8%
0.04%
-15.1%
Q3 2022$133,000
+4.7%
5,068
+0.8%
0.05%
+12.8%
Q2 2022$127,000
+1.6%
5,029
+27.2%
0.05%
-16.1%
Q1 2022$125,000
-26.0%
3,954
-5.4%
0.06%
-12.5%
Q4 2021$169,000
-44.0%
4,179
-51.8%
0.06%
-51.9%
Q3 2021$302,000
+20.8%
8,664
-4.9%
0.13%
+29.1%
Q2 2021$250,000
-4.6%
9,111
-2.5%
0.10%
-7.2%
Q1 2021$262,000
+9.6%
9,348
+1.7%
0.11%
+12.1%
Q4 2020$239,000
+25.8%
9,188
-17.0%
0.10%
-1.0%
Q3 2020$190,000
-39.1%
11,075
-12.1%
0.10%
-32.4%
Q2 2020$312,000
-22.0%
12,599
-56.1%
0.15%
+261.0%
Q3 2018$400,000
-34.3%
28,669
-42.4%
0.04%
-92.4%
Q2 2018$609,00049,7340.54%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders